Table 1. SAR, biological and computational results of the BIX-01294 derivatives a .
Compound ID | Scaffold | R2 | Activity% compound
b
(μM) |
IC50 c (μM) | c log P d | N-1 pK a e | Docking score (kcal mol–1) |
|||
50 | 10 | 1 | SP | XP | ||||||
1 (BIX-01294) | 6 | 6 | 11 | 0.067 ± 0.003 | 3.9 | 8.13 (±2.22) | –7.859 | na | ||
2 (HKMTI-1-005) | 5 | 6 | 19 | 0.101 ± 0.010 | 3.5 | 5.60 (±2.22) | –6.995 | –6.380 | ||
3 (HKMTI-1-022) | 7 | 9 | 35 | 0.472 ± 0.017 | 4.7 | 7.47 (±1.47) | –5.789 | –4.244 | ||
4 (HKMTI-1-011) | 15 | 31 | 79 | 3.190 ± 0.080 | 4.4 | 8.10 (±1.47) | na | na | ||
12 | 99 | 102 | 99 | — | 2.9 | 4.57 (±0.70) | na | na | ||
13 | 98 | 100 | 107 | — | 2.5 | 4.66 (±0.70) | na | na | ||
14 | 97 | 96 | 101 | — | 3.7 | 5.31 (±0.70) | na | na | ||
15 | 102 | 98 | 107 | — | 3.4 | 5.77 (±0.70) | na | na | ||
16 | 47 | 82 | 91 | — | 3.9 | 5.68 (±0.70) | na | na | ||
17 | 62 | 83 | 105 | — | 3.5 | 5.77 (±0.70) | na | na | ||
18 | 91 | 102 | 114 | — | 4.8 | 6.42 (±0.70) | na | na | ||
19 | 104 | 105 | 98 | — | 4.5 | 6.88 (±0.70) | na | na | ||
20 | 81 | 96 | 91 | — | 3.9 | 3.28 (±2.22) | na | na | ||
21 | 88 | 92 | 105 | — | 3.5 | 3.35 (±2.22) | na | na | ||
22 | 93 | 105 | 105 | — | 4.8 | 3.86 (±2.22) | na | na | ||
23 | 67 | 90 | 101 | — | 2.6 | 3.15 (±2.22) | na | na | ||
24 | 101 | 90 | 97 | — | 3.4 | 3.73 (±2.22) | na | na | ||
25 | 55 | 84 | 96 | — | 3.2 | 6.62 (±0.70) | na | na | ||
31 | 63 | 91 | 98 | — | 3.2 | 5.58 (±2.22) | na | na | ||
32 | 78 | 95 | 96 | — | 4.4 | 7.45 (±1.47) | na | na | ||
33 | 109 | 98 | 96 | — | 4.2 | 8.08 (±1.47) | na | na | ||
34 | 18 | 46 | 93 | — | 3.8 | 8.06 (±2.22) | na | na | ||
35 | 27 | 59 | 94 | — | 3.5 | 5.53 (±2.22) | na | na | ||
36 | 72 | 82 | 94 | — | 4.7 | 7.40 (±2.22) | na | na | ||
37 | 97 | 108 | 104 | — | 4.4 | 8.03 (±2.22) | na | na | ||
41 (HKMTI-1-248) | 5 | 4 | 6 | 0.013 ± 0.001 | 4.5 | 10.57 (±2.22) | –7.522 | –6.904 | ||
42 (HKMTI-1-247) | 5 | 6 | 7 | 0.031 ± 0.003 | 4.1 | 9.84 (±2.22) | na | –6.476 |
aR1 is the same for all compounds: R1 = , SP = standard precision mode, XP = extra precision mode, na = no desired pose found.
bThe experiment was conducted in duplicate.
cThe assay was conducted in triplicate at K m of both substrates (0.8 μM peptide [H3 1–25] and 8 μM SAM) for G9a (5 nM).17
d c log P values were calculated using the freely available program RDkit.34
e‘Sequential’ pK a values were calculated at pH 7.0, with water as the solvent model, using the Epik 2.7 program implemented in Schrodinger (see ESI).